Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations

Title
Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 17, Issue 1, Pages 17-25
Publisher
American Association for Cancer Research (AACR)
Online
2017-10-28
DOI
10.1158/1535-7163.mct-17-0146

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started